A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations

NCT03691207 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Adenoid Cystic Carcinoma

Interventions

DRUG: AL101

Sponsor

Ayala Pharmaceuticals, Inc,